Stockscreener 앱 받기
0.017
20.52%
-0.0098
Viracta Therapeutics Inc 주식(VIRX)의 최신 뉴스
Fierce Biotech Layoff Tracker 2025: Relay sheds staff again; Sail lays off employees - Fierce Biotech
Layoff Tracker: BioAtla Streamlines Operations By Cutting 30% of Staff - BioSpace
Viracta Therapeutics (VIRX) to Release Quarterly Earnings on Thursday - Defense World
Calif. biotech company once worth $476M lays off every remaining employee - MSN
Viracta Therapeutics, Inc. (NASDAQ:VIRX) Sees Significant Decrease in Short Interest - Defense World
Semler Scientific (SMLR) Projected to Post Earnings on Tuesday - Defense World
Viracta Therapeutics to cease operations and seek alternatives - MSN
Finance Watch: Third Harmonic, Q32 Bio Cut Jobs To Focus On Lead Assets - insights.citeline.com
Procaps Group (NASDAQ:PROC) vs. Viracta Therapeutics (NASDAQ:VIRX) Financial Comparison - Defense World
🔬 Latest pharma industry updates 👇 - substack.com
VIRX stock plunges to 52-week low, touches $0.08 - MSN
Viracta Therapeutics Terminates Employees & Winds Down Operations - Contract Pharma
Viracta Winds Down Business, Unable to Weather Financial Troubles - BioSpace
Viracta Therapeutics Announces Wind Down of Operations - GlobeNewswire
AffyImmune’s layoffs; Henlius makes a biosimilar deal with Dr. Reddy’s - Endpoints News
Viracta Therapeutics to cease operations and seek alternatives By Investing.com - Investing.com South Africa
Viracta Therapeutics Announces Wind Down Of Operations - marketscreener.com
Viracta Therapeutics hits end of the line, laying off all workers and winding down - Fierce Biotech
Viracta Therapeutics Announces Wind-Down and Leadership Changes - TipRanks
Viracta Therapeutics Winds Down Operations, Terminates Employees - MarketWatch
Leerink Partners slashes price target on Viracta Therapeutics Inc [VIRX] – find out why. - The DBT News
Views of Wall Street’s Leading Experts on Viracta Therapeutics Inc - SETE News
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
VIRX’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
Analyzing VIRX’s price-to-book ratio for the last quarter - US Post News
Viracta Therapeutics to be delisted from Nasdaq - MSN
Pre-market Movers: SLGL, VIRX, ANVS, CUTR... - RTTNews
1.21%
1.51%
자본화:
|
볼륨(24시간):